Dianthus Therapeutics Banner

SEC Filing Details

Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Document Details

Form
Filing Date
Mar 12, 2026
Document Date
Mar 10, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/